Salix Coronary Plaque vs Zio AT ECG Monitoring System
AI Verdict
Choose Salix Coronary Plaque if…
Choose Salix Coronary Plaque if you require a rapid, AI-driven assessment of coronary artery plaque and stenosis directly from CCTA scans. This tool is ideal for point-of-care diagnosis and risk stratification of coronary artery disease, offering detailed quantification of plaque features and calcium scoring to inform immediate treatment strategies.
View Salix Coronary Plaque →Choose Zio AT ECG Monitoring System if…
Choose Zio AT ECG Monitoring System if continuous, long-term ECG monitoring is necessary to detect intermittent or asymptomatic cardiac arrhythmias. This wearable mobile cardiac telemetry service is best suited for patients experiencing infrequent symptoms like palpitations or syncope, or for those needing extended monitoring to capture elusive cardiac events that may not be present during shorter assessments.
View Zio AT ECG Monitoring System →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Salix Coronary Plaque | Zio AT ECG Monitoring System |
|---|---|---|
| Pricing | Subscription model | Contact for pricing |
| Deployment | Cloud-based (Amazon Web Services), web-based software application | Cloud-based (data analytics and clinician portal) |
| BAA Available | Yes AI-estimated | Yes AI-estimated |
| FDA Status | Yes AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Salix Coronary PlaqueTool A, Salix Coronary Plaque, offers a highly integrated and efficient web-based software experience for clinicians, providing near real-time, point-of-care CCTA assessment and automated report generation within minutes. Its design focuses on streamlining existing workflows without requiring multiple systems or external reading teams, enhancing direct physician control and efficiency.
Clinical Value
Salix Coronary PlaqueBoth tools offer significant clinical value, but Tool A, Salix Coronary Plaque, stands out by non-invasively detecting and quantifying specific high-risk plaque features (e.g., low-attenuation plaque, napkin-ring sign) from CCTA scans that are often missed by traditional methods. This capability provides a more precise prediction of heart attacks and can shift treatment paradigms towards preventative care for coronary artery disease.
Pricing & Value
Salix Coronary PlaqueTool A, Salix Coronary Plaque, provides greater transparency regarding its economic value by explicitly stating a 'per-scan assessment model' and mentioning a US CPT reimbursement rate of US$950 per assessment. This offers a clear financial proposition and predictable revenue stream for healthcare providers.
Enterprise Readiness
Zio AT ECG Monitoring SystemTool B, Zio AT ECG Monitoring System, explicitly states its HIPAA compliance and the availability of a Business Associate Agreement (BAA) in its structured facts. Furthermore, it is SOC 2 Type II certified and has FIPS 140-2 validation for data encryption, offering comprehensive and transparent assurances critical for enterprise adoption and data security in healthcare.
Innovation
Salix Coronary PlaqueWhile both are innovative, Tool A, Salix Coronary Plaque, demonstrates a more profound innovation by leveraging AI for the non-invasive identification and quantification of specific high-risk, vulnerable plaque features from CCTA scans. These features are crucial predictors of heart attacks often overlooked by conventional diagnostics, representing a significant advancement in prognostic capabilities for coronary artery disease.
Support & Docs
Zio AT ECG Monitoring SystemTool B, Zio AT ECG Monitoring System, provides extensive support resources, including a dedicated 24/7 Customer Care phone number, detailed Clinical Reference Manuals, Instructions for Use, and comprehensive FAQs for both patients and clinicians. This breadth and explicit availability of support are more clearly demonstrated than for Tool A.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Salix Coronary Plaque | Zio AT ECG Monitoring System |
|---|---|---|
| Tool Name | Salix Coronary Plaque | Zio AT ECG Monitoring System |
| Company | Artrya Limited | iRhythm Technologies, Inc. |
| Description | FDA-cleared, AI-driven, web-based software that provides near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease. | FDA-cleared, wearable mobile cardiac telemetry (MCT) service offering continuous, AI-powered ECG monitoring for long-term arrhythmia detection and comprehensive reporting. |
| Primary Function | Coronary artery plaque and stenosis assessment from CCTA scans | Continuous ECG monitoring for long-term arrhythmia detection |
| Key Features (Examples) | AI-enabled CCTA analysis, Near real-time, point-of-care assessment, Detection and quantification of coronary plaque | Wearable Zio AT patch for continuous ECG recording, Wireless gateway for real-time data transmission, FDA-cleared deep-learned AI algorithm (ZEUS System) for arrhythmia detection |
Videos
Demos, reviews, and walkthroughs featuring Salix Coronary Plaque and Zio AT ECG Monitoring System.
Frequently Asked Questions
More Comparisons
More matchups featuring Salix Coronary Plaque or Zio AT ECG Monitoring System
Backers
Who funded each tool's parent company.